FDA approves Roche’s assay to identify lung cancer in patients eligible for lorbrena

Roche gets FDA approval for Ventana ALK (D5F3) CDx Assay. (Credit: F. Hoffmann-La Roche Ltd)



Related Article
Recommended Whitepaper

View More